In July, the stock market continued to rebound from the Brexit correction and experienced a rotation back toward large and medium capitalization growth stocks.
This was sparked by better than expected earnings at outfits like Microsoft, Amazon and Facebook. Also, biotechnology concerns such as Amgen and Biogen
chipped in with stellar results. On the year to date basis, however, value and dividend oriented stocks have outperformed growth by several percent. Read Full Article